MIRA INFORM REPORT

 

 

Report Date :

13.06.2007

 

IDENTIFICATION DETAILS

 

Name :

AFRICAN PHARMACEUTICAL AND DIAGNOSTICS (PTY) LTD

 

 

Registered Office :

3rd Floor, Park Terrace, 33 Princess of Wales Terrace, Parktown, Gauteng

 

 

Country :

South Africa

 

 

Date of Incorporation :

11 May 2004

 

 

Com. Reg. No.:

2004/012519/07

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Distributors of pharmaceuticals and diagnostics

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


COMPANY NAME

 

AFRICAN PHARMACEUTICAL AND DIAGNOSTICS (PTY) LTD

 

 

Formerly

 

BLACK GINGER 12 (PTY) LTD the name having been changed on 25 May 2004.

 

 

PHYSICAL ADDRESS

 

3rd Floor, Park Terrace

33 Princess of Wales Terrace

PARKTOWN

Gauteng

 

 

POSTAL ADDRESS

 

P O Box  31036

BRAAMFONTEIN

2017

TELEPHONE NUMBER: 011 481 3000

FAX NUMBER:              086 504 4518

 

 

SHAREHOLDERS

 

McARTHUR TRUST (Majority)

SIYANDISA TRADING TRUST

 

 

ASSOCIATE COMPANIES

 

None

 

 

DIRECTORS

 

D I McARTHUR                          ID No.   5606025162081

D R MOKHOBO             ID No.   6506115318081

 

 

BANKERS

 

NEDBANK City Branch.  Account Number 1031390944.  The subject does not require overdraft facilities at the bank as credit balances are maintained.

 

DATE REGISTERED

 

11 May 2004

Registration Certificate Number : 2004/012519/07.

 

It was stated by respondents that the subject commenced when the assets and operations of Med Works Investments (Pty) Ltd were incorporated into the company.  Med Works Investments (Pty) was established in 1999.

 

 

VAT NUMBER

 

4620218190

 

 

MAJOR OPERATION

 

Distributors of pharmaceuticals and diagnostics

 

 

MAJOR SUPPLIERS

 

The subject imports 90% of its supplies. The subject previously imported through UCB PHARMA SA and import now through SAFCOR in Port Elizabeth

 

 

MAJOR CUSTOMERS OR BUSINESS SECTORS

 

Government and Medical Industry

 

 

AREA OF DISTRIBUTION AND SELLING

 

South Africa

 

 

EXPORTS

 

African countries

 

 

TOTAL EMPLOYEES

 

5

 

 

OTHER PREMISES

 

None

 

 

OWNED OR LEASED

 

The premises are reported to be leased

 

 

AUTHORISED SHARE CAPITAL

 

R1000 divided into 1000 ordinary shares of R1 each

 

 

ISSUED SHARE CAPITAL

 

R100

           

The following estimated financial situation was submitted:

 

STOCK                                                             Minimal

DEBTORS                                                  R  1 000 000

CREDITORS                                               R     700 000

TURNOVER per annum                               R12 000 000

 

 

AUDITORS

 

LEON MARGOLIS CA (SNR)

 

 

YEAR END

 

FEBRUARY

 

 

INSURANCE BROKERS

 

RISK BENEFIT SOLUTIONS

 

 

TRADE REFERENCES

 

            PERIOD            HIGHEST          AVERAGE         TERMS             PAYMENT         EXPERIENCE

                                    CREDIT            CREDIT                                    PATTERN

 

1.         5 yrs                 R1 500 000        R   750 000-      30 days             30 days             Very Good

                                    c/l                     R1 500 000

 

The above trade reference was obtained from the subjects previous shipper as the new shippers’ account is very new.

 

 

COMMENTS

 

This is an established meeting its local commitment timeously.  We have not traced dealings to an extent of US$1 000 000 and would prefer to see a lesser amount well spread.

 

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions